The relation of soy intake and isoflavone levels in nipple aspirate fluid

European Journal of Cancer Prevention

Volumn 17, Issue 1, 2008, Pages 67-70

  Maskarinec, Gertraud ^a   Hebshi, Sandra ^a   Custer, Laurie ^a   Franke, Adrian A ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Breast cancer risk; Breast fluid; Diet and nutrition; Isoflavones; Soy foods

Indexed keywords

CARBON 13; DAIDZEIN; EQUOL; GENISTEIN; GLYCITEIN; ISOFLAVONE; ISOFLAVONOID; UNCLASSIFIED DRUG; WESTSOY PLUS PLAIN;

ADULT; ARTICLE; BLOOD SAMPLING; DILUTION; DRUG BLOOD LEVEL; DRUG EXCRETION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FOOD INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROLYSIS; ISOTOPE LABELING; LIQUID LIQUID EXTRACTION; NIPPLE ASPIRATION; NORMAL HUMAN; PILOT STUDY; PRIORITY JOURNAL; SOYBEAN MILK; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION;

ADOLESCENT; ADULT; DIET; FEASIBILITY STUDIES; FEMALE; HUMANS; ISOFLAVONES; MIDDLE AGED; NIPPLES; PILOT PROJECTS; SOY FOODS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 37349092992     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3281108101     Document Type: Article

References (25)

1. Barnes S, Boersma B, Patel R, Kirk M, Darley-Usmar VM, Kim H, Xu J (2000). Isoflavonoids and chronic disease: mechanisms of action. Biofactors 12:209-215.
2. Chatterton RT Jr, Geiger AS, Gann PH, Khan SA (2003). Formation of estrone and estradiol from estrone sulfate by normal breast parenchymal tissue. J Steroid Biochem Mol Biol 86:159-166.
3. Chatterton RT Jr, Geiger AS, Khan SA, Helenowski IB, Jovanovic BD, Gann PH (2004). Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev 13:928-935.
4. Ernster VL, Wrensch MR, Petrakis NL, King EB, Miike R, Murai J, et al. (1987). Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst. 79:949-960.
5. Fleishaker JC (2003). Models and methods for predicting drug transfer into human milk. Adv Drug Deliv Rev 55:643-652.
6. Franke AA, Custer L, Hundahl S (2004). Determinants for urinary and plasma isoflavones in humans after soy intake. Nutr Cancer 50:141-154.
7. Franke AA, Custer LJ, Tanaka Y (1998). Isoflavones in human breast milk and other biological fluids. Am J Clin Nutr 68:1466S-1473S.
8. Franke AA, Halm BM, Custer LJ, Tatsumura Y, Hebshi S (2006). Isoflavones in breastfed infants after mothers consume soy. Am J Clin Nutr 84:406-413.
9. Franke AA, Hankin JH, Yu MC, Maskarinec G, Low SH, Custer LJ (1999). Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. J Agric Food Chem 47:977-986.
10. Ganry O (2002). Phytoestrogen and breast cancer prevention. Eur J Cancer Prev 11:519-522.
11. Ito S, Lee A (2003). Drug excretion into breast milk: overview. Adv Drug Deliv Rev 55:617-627.
12. Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP (2004a). A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr 134:3089-3094.
13. Maskarinec G, Franke AA, Williams AE, Hebshi S, Oshiro C, Murphy SP, Stanczyk FZ (2004b). Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev 13: 1736-1744.
14. Maskarinec G, Singh S, Meng L, Franke AA (1998). Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev 7:613-619.
15. Maskarinec G, Williams AE, Carlin L (2003). Mammographic densities in a one-year isoflavone intervention. Eur J Cancer Prev 12:165-169.
16. Messina M, Nagata C, Wu AH (2006). Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55:1-12.
17. Petrakis NL (1993). Nipple aspirate fluid in epidemiologic studies of breast disease. Epidemiol Rev 15:188-195.
18. Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, Lee MM, et al. (1996). Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 5:785-794.
19. Petrakis NL, Wrensch MR, Ernster VL, Miike R, Murai J, Simberg N, Siiteri PK (1987). Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 40:587-591.
20. Rose DP, Lahti H, Laakso K, Kettunen K, Wynder EL (1986). Serum and breast duct fluid prolactin and estrogen levels in healthy Finnish and American women and patients with fibrocystic disease. Cancer 57:1550-1554.
21. SAS Institute Inc. (2004). SAS OnlineDoc 9.1.2. Cary, NC: SAS Institute Inc.
22. Setchell KD (1998). Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68: 1333S-1346S.
23. Simpson ER (2003). Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86:225-230.
24. Trock BJ, Hilakivi-Clarke L, Clarke R (2006). Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98:459-471.
25. Williams AE, Maskarinec G, Hebshi S, Oshiro C, Murphy S, Franke AA (2003). Validation of a soy questionnaire with repeated dietary recalls and urinary isoflavone assessments over one year. Nutr Cancer 47:118-125.